Long-term diabetic complications in elderly patients with variable levels of HMGA1 expression
| Autor: | Antonio Brunetti, Stefania Iiritano, Francesco Paonessa, Daniela Foti, Eusebio Chiefari, Carmelo Capula, Katiuscia Possidente, Aurora Nocera, Biagio Arcidiacono |
|---|---|
| Jazyk: | angličtina |
| Rok vydání: | 2010 |
| Předmět: |
education.field_of_study
biology business.industry Metabolic disorder Population Type 2 Diabetes Mellitus Disease lcsh:Geriatrics medicine.disease Bioinformatics HMGA1 Insulin receptor lcsh:RC952-954.6 Diabetes mellitus Metabolic control analysis biology.protein medicine Geriatrics and Gerontology Meeting abstract education business |
| Zdroj: | BMC Geriatrics, Vol 10, Iss Suppl 1, p A91 (2010) Europe PubMed Central BMC Geriatrics |
| ISSN: | 1471-2318 |
| Popis: | Background Type 2 diabetes mellitus is a very common metabolic disorder affecting ~200 million people worldwide [1]. Chronic complications of the disease due to poor metabolic control are specifically associated with long-term damage, dysfunction and failure of various organs, causing blindness, renal failure, amputations, and increased risk of cardiovascular diseases [2]. Previously, we reported a novel genetic flaw that markedly reduced the intracellular expression of the high mobility group A1 (HMGA1) protein, and adversely affected insulin receptor expression in cells and tissues, leading to human diabetes [3]. Also, the involvement of HMGA1 in the transcriptional regulation of genes essential in both the inflammatory response and atherosclerosis is well known [4]. Herein we have investigated the prevalence of chronic complications in an elderly diabetic population according to the expression levels of HMGA1. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|
Full text from SpringerLink